Arabic Arabic English English French French German German
dark

Product-Specific Guidances for Complex Generic Drugs

Markham C. Luke from CDER’s Office of Generic Drugs discusses product-specific guidances for complex generic drugs.
Learn more at https://www.fda.gov/drugs/fda-product-specific-guidances-lighting-development-pathway-generic-drugs-05052021-05052021
_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training – https://www.fda.gov/cdersbia   
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist – https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn – https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance  
SBIA Training Resources – https://www.fda.gov/cderbsbialearn  
Twitter – https://twitter.com/FDA_Drug_Info  
Email – CDERSBIA@fda.hhs.gov  
Phone – (301) 796-6707 I (866) 405-5367

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Non-Complex Drug Products and Product-Specific Guidances

Next Post

Product-Specific Guidance Fundamentals from a Clinical Perspective

Related Posts
Total
0
Share